These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8462127

  • 41. Cytotoxicity and glutathione depletion by 1-methyl-2-nitrosoimidazole in human colon cancer cells.
    Mulcahy RT, Gipp JJ, Ublacker GA, Panicucci R, McClelland RA.
    Biochem Pharmacol; 1989 May 15; 38(10):1667-71. PubMed ID: 2730680
    [Abstract] [Full Text] [Related]

  • 42. Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents.
    Biroccio A, Benassi B, Fiorentino F, Zupi G.
    Neoplasia; 2004 May 15; 6(3):195-206. PubMed ID: 15153331
    [Abstract] [Full Text] [Related]

  • 43. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
    Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, Wilding G, Pomplun M, Spriggs DR.
    J Clin Oncol; 1994 Jan 15; 12(1):194-205. PubMed ID: 8270977
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.
    Andrews PA, Murphy MP, Howell SB.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6250-3. PubMed ID: 4063975
    [Abstract] [Full Text] [Related]

  • 46. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.
    Pendyala L, Perez R, Weinstein A, Zdanowicz J, Creaven PJ.
    Cancer Chemother Pharmacol; 1997 Dec 15; 40(1):38-44. PubMed ID: 9137527
    [Abstract] [Full Text] [Related]

  • 47. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ, Enger MD.
    Am J Physiol; 1992 Jan 15; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG.
    Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477
    [Abstract] [Full Text] [Related]

  • 50. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ.
    Cancer Res; 1993 Aug 15; 53(16):3662-6. PubMed ID: 8101766
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion.
    Andrews PA, Schiefer MA, Murphy MP, Howell SB.
    Chem Biol Interact; 1988 Aug 15; 65(1):51-8. PubMed ID: 3345573
    [Abstract] [Full Text] [Related]

  • 54. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.
    Friedman HS, Colvin OM, Griffith OW, Lippitz B, Elion GB, Schold SC, Hilton J, Bigner DD.
    J Natl Cancer Inst; 1989 Apr 05; 81(7):524-7. PubMed ID: 2921776
    [Abstract] [Full Text] [Related]

  • 55. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [Abstract] [Full Text] [Related]

  • 56. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 57. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells.
    Cammarata PR, Tse D, Yorio T.
    Curr Eye Res; 1991 Apr 15; 10(4):321-30. PubMed ID: 1676962
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Buthionine sulfoximine inhibition of cystine uptake and glutathione biosynthesis in human lung carcinoma cells.
    Brodie AE, Reed DJ.
    Toxicol Appl Pharmacol; 1985 Mar 15; 77(3):381-7. PubMed ID: 3975906
    [Abstract] [Full Text] [Related]

  • 60. Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.
    Bailey HH, Ripple G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Mahvi D, Schink J, Pomplun M, Mulcahy RT, Wilding G.
    J Natl Cancer Inst; 1997 Dec 03; 89(23):1789-96. PubMed ID: 9392620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.